Future FinTech Group Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Future FinTech Group Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.83M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $2.11M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $21.70M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $23.88M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $25.05M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $368.7K | Mar 22, 2023 |
| FY2020 | Dec 31, 2019 | $941.1K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $888.7K | Nov 4, 2020 |
| FY2018 | Dec 31, 2017 | $10.46M | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | $34.41M | Apr 16, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $408.3K | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.24M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $1.12M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $5.40M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $1.80M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $333.7K | Mar 22, 2023 |
| FY2020 | Dec 31, 2019 | $450.0K | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($86.4K) | Nov 4, 2020 |
| FY2018 | Dec 31, 2017 | $1.73M | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | $9.17M | Apr 16, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($4.62M) | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | ($32.96M) | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | ($33.65M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($13.63M) | Apr 16, 2024 |
| FY2021 | Dec 31, 2021 | $14.21M | Mar 22, 2023 |
| FY2021 | Dec 31, 2020 | ($88.93M) | Mar 22, 2023 |
| FY2020 | Dec 31, 2019 | ($27.07M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($170.00M) | Nov 4, 2020 |
| FY2018 | Dec 31, 2017 | ($102.58M) | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | ($5.29M) | Apr 16, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($34.01M) | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | ($32.89M) | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | ($23.59M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($16.81M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($13.21M) | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | ($15.05M) | Mar 22, 2023 |
| FY2020 | Dec 31, 2019 | ($7.58M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($190.52M) | Nov 4, 2020 |
| FY2018 | Dec 31, 2017 | ($99.09M) | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | $2.23M | Apr 16, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $312.9K | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $340.4K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $2.67M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $698.1K | Apr 19, 2023 |
| FY2014 | Dec 31, 2013 | $20.2K | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $570.3K | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $557.4K | Mar 29, 2013 |
| FY2011 | Dec 31, 2010 | $1.09M | Mar 28, 2012 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $185.2K | Apr 19, 2023 |
| FY2022 | Dec 31, 2021 | $57.6K | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $1.5K | Mar 22, 2023 |
| FY2013 | Dec 31, 2013 | $1.14M | Mar 31, 2014 |
| FY2013 | Dec 31, 2012 | $391.5K | Mar 31, 2014 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $2.69M | Apr 19, 2023 |
| FY2019 | Dec 31, 2019 | ($15.84M) | Nov 4, 2020 |
| FY2019 | Dec 31, 2018 | ($4.88M) | Nov 4, 2020 |
| FY2018 | Dec 31, 2017 | $23.66M | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | ($34.44M) | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $104.26M | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | $4.18M | Nov 28, 2016 |
| FY2014 | Dec 31, 2013 | $24.91M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $19.70M | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $25.98M | Mar 29, 2013 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.7K | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $34.1K | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $65.7K | Apr 15, 2025 |
| FY2020 | Dec 31, 2020 | $3.0K | Apr 15, 2021 |
| FY2020 | Dec 31, 2019 | $5.0K | Apr 15, 2021 |
| FY2017 | Dec 31, 2016 | $8.73M | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | $279.7K | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | $15.38M | Nov 28, 2016 |
| FY2014 | Dec 31, 2013 | $12.62M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $7.03M | Mar 31, 2014 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.29M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $35.48M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $60.94M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $85.02M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $91.66M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $15.93M | Mar 22, 2023 |
| FY2020 | Dec 31, 2019 | $115.98M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $62.95M | Nov 4, 2020 |
| FY2018 | Dec 31, 2017 | $190.68M | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | $261.66M | Apr 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.33M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $22.88M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $18.53M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $19.33M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $10.80M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $7.20M | Mar 22, 2023 |
| FY2020 | Dec 31, 2019 | $204.06M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | $149.62M | Nov 4, 2020 |
| FY2018 | Dec 31, 2017 | $157.73M | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | $91.47M | Apr 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.96M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $14.46M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $43.98M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $66.97M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $81.44M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | $8.78M | Mar 22, 2023 |
| FY2020 | Dec 31, 2019 | ($92.44M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($91.28M) | Nov 4, 2020 |
| FY2018 | Dec 31, 2017 | $12.61M | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | $135.03M | Apr 16, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2022 | $13.98M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $15.58M | Apr 19, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($223.51M) | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | ($218.89M) | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | ($185.93M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($152.28M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($138.61M) | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | ($124.38M) | Mar 22, 2023 |
| FY2020 | Dec 31, 2019 | ($213.31M) | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | ($188.09M) | Nov 4, 2020 |
| FY2018 | Dec 31, 2017 | ($2.35M) | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | $100.24M | Apr 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.40M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $4.77M | Mar 18, 2026 |
| FY2021 | Dec 31, 2021 | $50.27M | Mar 22, 2023 |
| FY2021 | Dec 31, 2020 | $9.43M | Mar 22, 2023 |
| FY2021 | Dec 31, 2019 | $526.8K | Mar 22, 2023 |
| FY2020 | Dec 31, 2018 | $19.7K | Apr 15, 2021 |
| FY2019 | Dec 31, 2017 | $4.59M | Nov 4, 2020 |
| FY2018 | Dec 31, 2016 | $1.14M | Sep 3, 2019 |
| FY2017 | Dec 31, 2015 | $50.01M | Apr 16, 2018 |
| FY2016 | Dec 31, 2014 | $25.13M | Apr 17, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2021 | $188.2K | Apr 19, 2023 |
| FY2018 | Dec 31, 2018 | $15.75M | Sep 3, 2019 |
| FY2018 | Dec 31, 2017 | $6.12M | Sep 3, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | (62) | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | (2) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
| FY2019 | Dec 31, 2019 | 0 | Nov 4, 2020 |
| FY2019 | Dec 31, 2018 | (7) | Nov 4, 2020 |
| FY2018 | Dec 31, 2017 | (21) | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | (1) | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | 0 | Nov 28, 2016 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | (63) | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | (2) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | 2 | Mar 22, 2023 |
| FY2020 | Dec 31, 2019 | 0 | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | (7) | Nov 4, 2020 |
| FY2018 | Dec 31, 2017 | (18) | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | (1) | Apr 16, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5.05M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | 611,771 | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | 17.83M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 14.65M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 14.04M | Apr 19, 2023 |
| FY2021 | Dec 31, 2020 | 50.05M | Mar 22, 2023 |
| FY2020 | Dec 31, 2019 | 33.81M | Apr 15, 2021 |
| FY2019 | Dec 31, 2018 | 31.02M | Nov 4, 2020 |
| FY2018 | Dec 31, 2017 | 5.37M | Sep 3, 2019 |
| FY2017 | Dec 31, 2016 | 4.06M | Apr 16, 2018 |